Nonventilatory interventions in ALI/ARDS: Recent work

Journal of Intensive Care Medicine

Volumn 23, Issue 1, 2008, Pages 70-72

  Tidswell, Mark ^a,b  

^a BAYSTATE MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; ANTIFIBROTIC AGENT; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; CELL ADHESION MOLECULE; CHEMOKINE; CORTICOSTEROID; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR ANTIBODY; GROWTH FACTOR; HEAT SHOCK PROTEIN; HIGH MOBILITY GROUP B1 PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 6; KERATINOCYTE GROWTH FACTOR; KETOCONAZOLE; LEUKOTRIENE; LISOFYLLINE; MATRIX PROTEIN; METHYLPREDNISOLONE; NITRIC OXIDE; OXIDIZING AGENT; PHOSPHODIESTERASE INHIBITOR; PLACEBO;

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; ARTIFICIAL VENTILATION; CLINICAL TRIAL; DRUG EFFICACY; DRUG RESEARCH; EDITORIAL; HUMAN; PRIORITY JOURNAL; TREATMENT PLANNING;

HUMANS; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 38349006257     PISSN: 08850666     EISSN: 15251489     Source Type: Journal    
DOI: 10.1177/0885066607310179     Document Type: Editorial

References (15)

1. Ashbaugh DG, Bigelow DB, Petty TL, Levine BE Acute respiratory distress in adults. Lancet. 1967 ; 12: 319-323.
2. Peace RJ The role of the alveolar lining cells in reaction to lung injury. Southern Med J. 1960 ; 53: 650-651.
3. Ware LB, Matthay M., The acute respiratory distress syndrome. N Engl J Med. 2000 ; 342: 1334-1349.
4. Notter RH, Finkelstein JN, Holm BA, eds. Lung Injury: Mechanisms, Pathophysiology, and Therapy. Volume 196 in the series Lung Biology in Health and Disease. Boca Raton, FL: Taylor and Francis ; 2005.
5. Imai Y., Parodo J., Kajikawa O., et al. Injurious mechanical ventilation and end-organ epithelial cell apoptosis and organ dysfunction in an experimental model of acute respiratory distress syndrome. JAMA 2003 ; 289: 2104-2112.
6. Doyle RL, Szaflarski N., Modin G., et al. Identification of patients with acute lung injury: predictors of mortality. Am J Respir Crit Care Med. 1995 ; 152: 1818-1824.
7. The National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000 ; 342: 1301-1308.
8. Bernard GR, Luce JM, Sprung G., et al. High-dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med. 1987 ; 317: 1565-1570.
9. Meduri GU, Headley AS, Golden E., et al. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA 1998 ; 280: 159-165.
10. The National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med. 2006 ; 354: 1671-1684.
11. Annane D. Glucocorticoids for ARDS. Chest. 2007 ; 131: 945-946.
12. Meduri GU, Golden E., Freire AX, et al. Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial. Chest. 2007 ; 131: 954-963.
13. The National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med. 2006 ; 354: 2564-2575.
14. Tidswell M. Prone ventilation. Clin Intensive Care. 2001 ; 12: 193-201.
15. Davidson WJ, Dorscheid D., Spragg R., et al. Exogenous pulmonary surfactant for the treatment of adult patients with acute respiratory distress syndrome: results of a meta-analysis. Crit Care. 2006 ; 10: R41.